… SARS-CoV-2 is an enveloped positive-stranded RNA virus … advanced our knowledge of the SARS-CoV-2 entry process (… the molecular mechanisms of the enhancedinfectivity of B.1.1.…
SARS-CoV-2 Lambda, a variant of interest, has spread in some South American countries; however, its virological features and evolutionary traits remain unclear. In this study, we use …
SR Kannan, AN Spratt, TP Quinn, X Heng… - Journal of Neuroimmune …, 2020 - Springer
… enhances the infectivity of SARS-CoV-2 virus. However, it is highly unlikely that a seemingly high infection rate of SARS-CoV-2 is … to the viral replication, infectivity, or a combination of …
… and a fourth plasmid encoding luciferase mRNA linked to a SARS-CoV-2 packaging signal (3). … structural gene variants on infectivity, we used the structural genes from SARS-CoV-2 B.1 …
Z Cui, P Liu, N Wang, L Wang, K Fan, Q Zhu, K Wang… - Cell, 2022 - cell.com
… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … in increased transmissibility, infectivity, and immune escape as … for enhancedinfectivity and immune evasion of SARS-CoV-2 …
M Takeda - Microbiology and immunology, 2022 - Wiley Online Library
… mode of SARS-CoV-2 infection. SARS-CoV-2 variants with enhancedinfectivity have been … , and there is a close relationship between enhancedinfectivity and changes in S protein …
Y Fan, X Li, L Zhang, S Wan, L Zhang… - Signal transduction and …, 2022 - nature.com
… L at the S2 site mediates two distinct SARS-CoV-2 entry pathways. As … enhancing infectivity. However, the cleavage level of Omicron by furin is the weakest among the SARS-CoV-2 …
S Yang, Y Yu, F Jian, W Song, A Yisimayi… - The Lancet Infectious …, 2023 - thelancet.com
… 2.86’s RBD are likely to enhance immune evasion as previously reported. 1, 2 Many unusual … Therefore, an experimental assessment of the antigenicity and infectivity of BA. 2.86 is …
… , the evolutionary fate of SARS-CoV-2 becomes a matter of … mechanistic clues on the enhanced infectivity. The D614G … of reducing the infection efficacy of SARS-CoV-2. This therapeutic …